Published • loading... • Updated
United Therapeutics (NASDAQ:UTHR) Director Sells $701,800.00 in Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
United Therapeutics (NASDAQ:UTHR) Director Sells $701,800.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Patusky sold 1,210 shares of the stock in a transaction on Monday, November 9th. The shares were sold at an average price of $580.00, for a total transaction of $701,800.00. Following the completion of the sale, the director directly owned 2,140 shares in the company, valued at approximately $1,241,200. This represents a 36.12% decrease in their position. The sa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
